CTOR

SEC source: 0001213900-25-090615 · ownership.xml · nonDerivative · entry 1

Smith Robert Joseph · CIK 0002008764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090617 · ownership.xml · nonDerivative · entry 2

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 100,000

F2 · ownership.nature: Represents restricted stock awards granted on September 19, 2025 to the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.

SEC source: 0001213900-25-090617 · ownership.xml · nonDerivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 850,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090614 · ownership.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,700,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090613 · ownership.xml · nonDerivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090611 · ownership.xml · nonDerivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 825,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090612 · ownership.xml · nonDerivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090609 · ownership.xml · nonDerivative · entry 1

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 825,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090608 · ownership.xml · nonDerivative · entry 1

Mayersohn Joel David · CIK 0001588395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,228

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090616 · ownership.xml · nonDerivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-090610 · ownership.xml · nonDerivative · entry 1

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116676 · ownership.xml · nonDerivative · entry 1

Smith Robert Joseph · CIK 0002008764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116682 · ownership.xml · nonDerivative · entry 1

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116680 · ownership.xml · nonDerivative · entry 1

Mayersohn Joel David · CIK 0001588395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,228

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116681 · ownership.xml · nonDerivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116679 · ownership.xml · nonDerivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116677 · ownership.xml · nonDerivative · entry 1

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 825,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116678 · ownership.xml · nonDerivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 850,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116673 · ownership.xml · nonDerivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 825,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116675 · ownership.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,700,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-116674 · ownership.xml · nonDerivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124532 · ownership.xml · nonDerivative · entry 1

Smith Robert Joseph · CIK 0002008764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124537 · ownership.xml · nonDerivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124536 · ownership.xml · nonDerivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 850,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124534 · ownership.xml · nonDerivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 825,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124535 · ownership.xml · nonDerivative · entry 1

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 825,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124533 · ownership.xml · nonDerivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,700,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124531 · ownership.xml · nonDerivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124530 · ownership.xml · nonDerivative · entry 1

Mayersohn Joel David · CIK 0001588395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,228

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124529 · ownership.xml · nonDerivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-124528 · ownership.xml · nonDerivative · entry 1

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

F1 · shares: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.

SEC source: 0001213900-25-073136 · ownership.xml · nonDerivative · entry 1

Mayersohn Joel David · CIK 0001588395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,228

F1 · shares: The shares were acquired through a distribution in kind to limited partners of 10XYZ Holdings, which was the Sponsor of TenX Keane Acquisition ("TenX"), the legacy entity of Citius Oncology, Inc.

SEC source: 0001213900-24-109301 · ownership.xml · derivative · entry 1

Smith Robert Joseph · CIK 0002008764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

SEC source: 0001213900-24-109305 · ownership.xml · derivative · entry 1

Holuka Eugene Myron · CIK 0001678292 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

SEC source: 0001213900-24-109376 · ownership.xml · derivative · entry 1

Mayersohn Joel David · CIK 0001588395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date

SEC source: 0001213900-24-109304 · ownership.xml · derivative · entry 2

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Secretary

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-12-12

F2 · derivative.exercise_date: These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.

F2 · ownership.nature: These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.

SEC source: 0001213900-24-109304 · ownership.xml · derivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director · Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.

SEC source: 0001213900-24-109300 · ownership.xml · derivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

SEC source: 0001213900-24-109299 · ownership.xml · derivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.

SEC source: 0001213900-24-109298 · ownership.xml · derivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date

SEC source: 0001213900-24-109295 · ownership.xml · derivative · entry 1

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.

SEC source: 0001213900-24-109293 · ownership.xml · derivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.

SEC source: 0001213900-24-109292 · ownership.xml · derivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2034-12-12

F1 · derivative.exercise_date: These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date.

SEC source: 0001213900-24-069251 · ownership.xml · derivative · entry 1

Dutia Suren G · CIK 0001514063 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-07-05

F1 · derivative.exercise_date: This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.

SEC source: 0001213900-24-069250 · ownership.xml · derivative · entry 1

HOLUBIAK MYRON Z · CIK 0001199080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-07-05

F1 · derivative.exercise_date: This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.

SEC source: 0001213900-24-069249 · ownership.xml · derivative · entry 1

Czuczman Myron · CIK 0001817716 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466,667

Underlying: Common Stock · 466,667 shares

Expires 2033-07-05

F1 · derivative.exercise_date: This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.

SEC source: 0001213900-24-069248 · ownership.xml · derivative · entry 1

Mazur Leonard L · CIK 0001463414 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,233,333

Underlying: Common Stock · 1,233,333 shares

Expires 2033-07-05

F1 · derivative.exercise_date: This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.

SEC source: 0001213900-24-069247 · ownership.xml · derivative · entry 1

Bartushak Jaime · CIK 0001725077 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466,667

Underlying: Common Stock · 466,667 shares

Expires 2033-07-05

F1 · derivative.exercise_date: This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.

SEC source: 0001213900-24-069246 · ownership.xml · derivative · entry 1

MCGRATH DENNIS M · CIK 0001269340 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-07-05

F1 · derivative.exercise_date: This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.

SEC source: 0001213900-24-069244 · ownership.xml · derivative · entry 1

Webb Carol · CIK 0001671111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-07-05

F1 · derivative.exercise_date: This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024.